Royalty Pharma plc
US ˙ NasdaqGS ˙ GB00BMVP7Y09

SecurityRPRX / Royalty Pharma plc
InstitutionCALVERT VARIABLE SERIES INC - Calvert VP SRI Mid Cap Portfolio
Latest Disclosed Ownership15,492 shares
Latest Disclosed Value $ 558,176
CALVERT VARIABLE SERIES INC - Calvert VP SRI Mid Cap Portfolio ownership in RPRX / Royalty Pharma plc

On August 25, 2025 - CALVERT VARIABLE SERIES INC - Calvert VP SRI Mid Cap Portfolio filed a NPORT-P form disclosing ownership of 15,492 shares of Royalty Pharma plc (US:RPRX) valued at $558,177 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 15,492 shares of Royalty Pharma plc. This represents a change in shares of 0.00% during the quarter. The current value of the position is $851,595 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-25 2025-06-30 NP Royalty Pharma EC GB00BMVP7Y09 15,492 0 0.00 558 15.77 2.3529
2025-05-28 2025-03-31 NP Royalty Pharma EC GB00BMVP7Y09 15,492 0 0.00 482 22.03 1.9579
2025-02-19 2024-12-31 NP Royalty Pharma EC GB00BMVP7Y09 15,492 390 2.58 395 -7.49 1.5526
2024-11-27 2024-09-30 NP Royalty Pharma EC GB00BMVP7Y09 15,102 364 2.47 427 10.05 1.6195
2024-08-20 2024-06-30 NP Royalty Pharma EC GB00BMVP7Y09 14,738 0 0.00 389 -13.20 1.5670
2024-05-28 2024-03-31 NP Royalty Pharma EC GB00BMVP7Y09 14,738 0 0.00 448 8.23 1.6693
2024-02-02 2023-12-31 NP Royalty Pharma EC GB00BMVP7Y09 14,738 471 3.30 414 6.72 1.6020
2023-11-29 2023-09-30 NP Royalty Pharma EC GB00BMVP7Y09 14,267 490 3.56 387 -8.51 1.6129
2023-08-22 2023-06-30 NP Royalty Pharma EC GB00BMVP7Y09 13,777 981 7.67 424 -8.24 1.6074
2023-05-26 2023-03-31 NP Royalty Pharma EC GB00BMVP7Y09 12,796 0 0.00 461 -8.71 1.7346
2023-03-01 2022-12-31 NP Royalty Pharma EC GB00BMVP7Y09 12,796 0 0.00 506 -1.75 1.9393
2022-11-28 2022-09-30 NP Royalty Pharma EC GB00BMVP7Y09 12,796 0 0.00 514 -4.28 2.0957
2022-08-22 2022-06-30 NP Royalty Pharma EC GB00BMVP7Y09 12,796 9,485 286.47 538 286.33 2.0385
2020-11-25 2020-09-30 NP Royalty Pharma EC GB00BMVP7Y09 3,311 944 39.88 139 21.93 0.4360
2020-08-24 2020-06-30 NP Royalty Pharma EC GB00BMVP7Y09 2,367 2,367 115 0.3726
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.